Molecular pharmacokinetic determinants of anticancer kinase inhibitors in humans
This review presents the published data regarding the molecular determinants (drug metabolizing enzymes, drug transporters
and orphan nuclear receptors) of approved anticancer kinase inhibitors pharmacokinetics in humans. The clinical impact of
these determinants (drug disposition and drug–drug interactions) is also discussed.